# pathway_0063: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0063.txt)

**Task:** `pathway`  
**Author key, unchanged:** **C** — Antifungal biosynthesis. .

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MLHSASVIFLSLSVLAAVGVWGPFVRDGGFDAMDAVVARHPSTGIPGLQHYPEFDRGLMSIVAFNLSAVNSIAYCFMMQFLANVAVIPVILCTEDSSAAPGSWVRYSTIWGLLSQLGTSAVIYPLYAMSFIRQSSREPSQTRQPMSDMALILNMAMGYALPAAITLNVLHSSLNMQIWGILAFTVYPICMKLMARIIKVFTGFRKFPTRSRHQSIPTLRYAVAGGVALQGHLWYLGTELGIFKGHTPSLSAEKMDSEGGARLVLRFLQVDYAITFLAMLLLAWHELIYHRILPAWRALGGLIIGWILVGPGATLAAAWYLRSRFIMAPGKRKKRYGD

[Multiple Choices]
A. L-leucine degradation
B. Polyketide biosynthesis. .
C. Antifungal biosynthesis. .
D. pyruvate from D-glyceraldehyde 3-phosphate: step 2/5. .
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the UniProt entry for a terpene cyclase annotated to the antifungal biosynthesis pathway. The annotation cites a research paper, though the supplied evidence does not independently establish the experimental basis of that pathway assignment.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is strongly hydrophobic and likely membrane-associated, which makes several options such as glycolysis less plausible. But that does not identify its specific biosynthetic pathway or reliably distinguish antifungal from other biosynthesis.


**Missing item-specific fact**

> The protein-specific assignment as a terpene cyclase in the antifungal biosynthesis pathway, or equivalent knowledge of its biosynthetic-cluster context.


**Reason**

> The sequence and choices provide at most broad functional clues; selecting C requires an item-specific functional or pathway annotation not supplied in the question.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The sequence alone does not discriminate the choices reliably, but the sequence-matched annotation supports C rather than establishing another option.


### Important caveats

- The annotation is database evidence linked to a 2021 publication; the provided excerpts do not independently verify the experimental evidence for the pathway assignment.
- The current and archived UniProt records match the supplied sequence, but the author's exact source snapshot is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is strongly hydrophobic and likely membrane-associated, which makes several options such as glycolysis less plausible. But that does not identify its specific biosynthetic pathway or reliably distinguish antifungal from other biosynthesis.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific assignment as a terpene cyclase in the antifungal biosynthesis pathway, or equivalent knowledge of its biosynthetic-cluster context.",
    "reason": "The sequence and choices provide at most broad functional clues; selecting C requires an item-specific functional or pathway annotation not supplied in the question."
  },
  "case_id": "pathway_0063",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for a terpene cyclase annotated to the antifungal biosynthesis pathway. The annotation cites a research paper, though the supplied evidence does not independently establish the experimental basis of that pathway assignment."
  },
  "important_caveats": [
    "The annotation is database evidence linked to a 2021 publication; the provided excerpts do not independently verify the experimental evidence for the pathway assignment.",
    "The current and archived UniProt records match the supplied sequence, but the author's exact source snapshot is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The sequence alone does not discriminate the choices reliably, but the sequence-matched annotation supports C rather than establishing another option."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0063",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for a terpene cyclase annotated to the antifungal biosynthesis pathway. The annotation cites a research paper, though the supplied evidence does not independently establish the experimental basis of that pathway assignment.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is strongly hydrophobic and likely membrane-associated, which makes several options such as glycolysis less plausible. But that does not identify its specific biosynthetic pathway or reliably distinguish antifungal from other biosynthesis.",
    "missing_item_specific_fact": "The protein-specific assignment as a terpene cyclase in the antifungal biosynthesis pathway, or equivalent knowledge of its biosynthetic-cluster context.",
    "reason": "The sequence and choices provide at most broad functional clues; selecting C requires an item-specific functional or pathway annotation not supplied in the question."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The sequence alone does not discriminate the choices reliably, but the sequence-matched annotation supports C rather than establishing another option."
  },
  "important_caveats": [
    "The annotation is database evidence linked to a 2021 publication; the provided excerpts do not independently verify the experimental evidence for the pathway assignment.",
    "The current and archived UniProt records match the supplied sequence, but the author's exact source snapshot is unknown."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry P0DXW1 explicitly annotates the pathway as 'Antifungal biosynthesis' (evidence code ECO:0000305, curator inference from PubMed:33857369). The protein is a terpene cyclase (EC 5.4.99.-) in the lanomycin biosynthetic gene cluster of Pyrenophora dematioidea; lanomycin is a CYP51-inhibiting antifungal natural product. The sequence matches the UniProt entry exactly (337 aa, SHA-256 match). The pathway annotation is a curator-assigned category tied to the specific biosynthetic gene cluster context.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> Elimination provides partial reasoning: polyketide synthases (B) are typically >1000 aa multi-domain enzymes, making a 337-aa protein implausible; glycolytic enzymes (D) are cytosolic and structurally distinct; leucine-degradation enzymes (A) are typically mitochondrial/cytosolic without a signal peptide. The presence of a signal peptide and multiple transmembrane helices is inconsistent with A, B, and D. However, the positive identification of 'Antifungal biosynthesis' as the pathway cannot be derived from sequence features alone — terpene cyclases participate in steroid biosynthesis, diterpene biosynthesis, carotenoid pathways, and many other routes. The specific assignment to 'Antifungal biosynthesis' depends on knowing this protein belongs to the lanomycin BGC.


**Missing item-specific fact**

> The specific biosynthetic gene cluster identity (lanomycin cluster, ORF5) and the curator-assigned pathway category 'Antifungal biosynthesis' from UniProt, which links this terpene cyclase to antifungal natural-product biosynthesis rather than any other terpene cyclase pathway.


**Reason**

> While elimination of A, B, and D is somewhat feasible from general sequence features (size, membrane topology, domain architecture), the positive identification of 'Antifungal biosynthesis' as the pathway requires item-specific database knowledge about the lanomycin BGC. The pathway label itself is a UniProt-specific categorization not derivable from sequence motifs.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Among the four choices, C is the only one not clearly contradicted by sequence features. A, B, and D are eliminable by size, domain architecture, and subcellular-topology reasoning. However, the positive support for C is weak without external knowledge, making the question answerable by elimination but not by direct positive identification from the sequence.


### Important caveats

- The pathway annotation 'Antifungal biosynthesis' uses evidence code ECO:0000305 (inferred by curator), not direct experimental pathway reconstitution. The underlying paper (PubMed:33857369) characterizes the lanomycin BGC and identifies CYP51-inhibitory activity.
- The protein is a terpene cyclase; calling its pathway 'Antifungal biosynthesis' reflects the biological role of its product (lanomycin) rather than a canonical metabolic pathway category. This is a UniProt-specific annotation convention.
- The organism (Pyrenophora dematioidea, a fungus) is not provided in the model input, removing a contextual clue that could support the antifungal-biosynthesis interpretation.
- The sequence-match to P0DXW1 is confirmed (SHA-256 match, 337 aa), but the accession was inferred from dataset metadata and was not available to the evaluated model.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "Elimination provides partial reasoning: polyketide synthases (B) are typically >1000 aa multi-domain enzymes, making a 337-aa protein implausible; glycolytic enzymes (D) are cytosolic and structurally distinct; leucine-degradation enzymes (A) are typically mitochondrial/cytosolic without a signal peptide. The presence of a signal peptide and multiple transmembrane helices is inconsistent with A, B, and D. However, the positive identification of 'Antifungal biosynthesis' as the pathway cannot be derived from sequence features alone — terpene cyclases participate in steroid biosynthesis, diterpene biosynthesis, carotenoid pathways, and many other routes. The specific assignment to 'Antifungal biosynthesis' depends on knowing this protein belongs to the lanomycin BGC.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific biosynthetic gene cluster identity (lanomycin cluster, ORF5) and the curator-assigned pathway category 'Antifungal biosynthesis' from UniProt, which links this terpene cyclase to antifungal natural-product biosynthesis rather than any other terpene cyclase pathway.",
    "reason": "While elimination of A, B, and D is somewhat feasible from general sequence features (size, membrane topology, domain architecture), the positive identification of 'Antifungal biosynthesis' as the pathway requires item-specific database knowledge about the lanomycin BGC. The pathway label itself is a UniProt-specific categorization not derivable from sequence motifs."
  },
  "case_id": "pathway_0063",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "UniProt entry P0DXW1 explicitly annotates the pathway as 'Antifungal biosynthesis' (evidence code ECO:0000305, curator inference from PubMed:33857369). The protein is a terpene cyclase (EC 5.4.99.-) in the lanomycin biosynthetic gene cluster of Pyrenophora dematioidea; lanomycin is a CYP51-inhibiting antifungal natural product. The sequence matches the UniProt entry exactly (337 aa, SHA-256 match). The pathway annotation is a curator-assigned category tied to the specific biosynthetic gene cluster context."
  },
  "important_caveats": [
    "The pathway annotation 'Antifungal biosynthesis' uses evidence code ECO:0000305 (inferred by curator), not direct experimental pathway reconstitution. The underlying paper (PubMed:33857369) characterizes the lanomycin BGC and identifies CYP51-inhibitory activity.",
    "The protein is a terpene cyclase; calling its pathway 'Antifungal biosynthesis' reflects the biological role of its product (lanomycin) rather than a canonical metabolic pathway category. This is a UniProt-specific annotation convention.",
    "The organism (Pyrenophora dematioidea, a fungus) is not provided in the model input, removing a contextual clue that could support the antifungal-biosynthesis interpretation.",
    "The sequence-match to P0DXW1 is confirmed (SHA-256 match, 337 aa), but the accession was inferred from dataset metadata and was not available to the evaluated model."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the four choices, C is the only one not clearly contradicted by sequence features. A, B, and D are eliminable by size, domain architecture, and subcellular-topology reasoning. However, the positive support for C is weak without external knowledge, making the question answerable by elimination but not by direct positive identification from the sequence."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0063",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry P0DXW1 explicitly annotates the pathway as 'Antifungal biosynthesis' (evidence code ECO:0000305, curator inference from PubMed:33857369). The protein is a terpene cyclase (EC 5.4.99.-) in the lanomycin biosynthetic gene cluster of Pyrenophora dematioidea; lanomycin is a CYP51-inhibiting antifungal natural product. The sequence matches the UniProt entry exactly (337 aa, SHA-256 match). The pathway annotation is a curator-assigned category tied to the specific biosynthetic gene cluster context.",
    "evidence_ids": ["C1", "C4", "C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "Elimination provides partial reasoning: polyketide synthases (B) are typically >1000 aa multi-domain enzymes, making a 337-aa protein implausible; glycolytic enzymes (D) are cytosolic and structurally distinct; leucine-degradation enzymes (A) are typically mitochondrial/cytosolic without a signal peptide. The presence of a signal peptide and multiple transmembrane helices is inconsistent with A, B, and D. However, the positive identification of 'Antifungal biosynthesis' as the pathway cannot be derived from sequence features alone — terpene cyclases participate in steroid biosynthesis, diterpene biosynthesis, carotenoid pathways, and many other routes. The specific assignment to 'Antifungal biosynthesis' depends on knowing this protein belongs to the lanomycin BGC.",
    "missing_item_specific_fact": "The specific biosynthetic gene cluster identity (lanomycin cluster, ORF5) and the curator-assigned pathway category 'Antifungal biosynthesis' from UniProt, which links this terpene cyclase to antifungal natural-product biosynthesis rather than any other terpene cyclase pathway.",
    "reason": "While elimination of A, B, and D is somewhat feasible from general sequence features (size, membrane topology, domain architecture), the positive identification of 'Antifungal biosynthesis' as the pathway requires item-specific database knowledge about the lanomycin BGC. The pathway label itself is a UniProt-specific categorization not derivable from sequence motifs."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the four choices, C is the only one not clearly contradicted by sequence features. A, B, and D are eliminable by size, domain architecture, and subcellular-topology reasoning. However, the positive support for C is weak without external knowledge, making the question answerable by elimination but not by direct positive identification from the sequence."
  },
  "important_caveats": [
    "The pathway annotation 'Antifungal biosynthesis' uses evidence code ECO:0000305 (inferred by curator), not direct experimental pathway reconstitution. The underlying paper (PubMed:33857369) characterizes the lanomycin BGC and identifies CYP51-inhibitory activity.",
    "The protein is a terpene cyclase; calling its pathway 'Antifungal biosynthesis' reflects the biological role of its product (lanomycin) rather than a canonical metabolic pathway category. This is a UniProt-specific annotation convention.",
    "The organism (Pyrenophora dematioidea, a fungus) is not provided in the model input, removing a contextual clue that could support the antifungal-biosynthesis interpretation.",
    "The sequence-match to P0DXW1 is confirmed (SHA-256 match, 337 aa), but the accession was inferred from dataset metadata and was not available to the evaluated model."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches a UniProt entry annotated for antifungal biosynthesis, with the annotation attributed to a 2021 paper; the entry also names the protein as a terpene cyclase. This supports the key as a curated pathway annotation, but the excerpts do not independently establish experimental validation of the pathway assignment.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

Empty string, as saved.


**Missing item-specific fact**

> The protein's specific association with an antifungal biosynthetic cluster or product is needed to select C; that connection is not apparent from the sequence alone.


**Reason**

> The sequence is strongly hydrophobic and suggests a membrane-associated protein, but that feature does not meaningfully distinguish antifungal biosynthesis from the offered alternatives. It lacks an evident pathway-specific signature in the provided input; selecting C depends on the protein-specific functional or cluster annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The sequence alone leaves the pathway uncertain, but the supplied evidence supports the author's keyed choice; no other option is independently supported as a pathway assignment.


### Important caveats

- The pathway evidence is a curated, literature-attributed annotation, not a direct experimental result shown in the supplied excerpts.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein's specific association with an antifungal biosynthetic cluster or product is needed to select C; that connection is not apparent from the sequence alone.",
    "reason": "The sequence is strongly hydrophobic and suggests a membrane-associated protein, but that feature does not meaningfully distinguish antifungal biosynthesis from the offered alternatives. It lacks an evident pathway-specific signature in the provided input; selecting C depends on the protein-specific functional or cluster annotation."
  },
  "case_id": "pathway_0063",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches a UniProt entry annotated for antifungal biosynthesis, with the annotation attributed to a 2021 paper; the entry also names the protein as a terpene cyclase. This supports the key as a curated pathway annotation, but the excerpts do not independently establish experimental validation of the pathway assignment."
  },
  "important_caveats": [
    "The pathway evidence is a curated, literature-attributed annotation, not a direct experimental result shown in the supplied excerpts."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The sequence alone leaves the pathway uncertain, but the supplied evidence supports the author's keyed choice; no other option is independently supported as a pathway assignment."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0063",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches a UniProt entry annotated for antifungal biosynthesis, with the annotation attributed to a 2021 paper; the entry also names the protein as a terpene cyclase. This supports the key as a curated pathway annotation, but the excerpts do not independently establish experimental validation of the pathway assignment.",
    "evidence_ids": ["C4", "C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "",
    "missing_item_specific_fact": "The protein's specific association with an antifungal biosynthetic cluster or product is needed to select C; that connection is not apparent from the sequence alone.",
    "reason": "The sequence is strongly hydrophobic and suggests a membrane-associated protein, but that feature does not meaningfully distinguish antifungal biosynthesis from the offered alternatives. It lacks an evident pathway-specific signature in the provided input; selecting C depends on the protein-specific functional or cluster annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The sequence alone leaves the pathway uncertain, but the supplied evidence supports the author's keyed choice; no other option is independently supported as a pathway assignment."
  },
  "important_caveats": [
    "The pathway evidence is a curated, literature-attributed annotation, not a direct experimental result shown in the supplied excerpts."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry P0DXW1 (LAN5_PYRDE) explicitly annotates the pathway as 'Antifungal biosynthesis' (ECO:0000305, curator inference from PubMed:33857369). The protein is a terpene cyclase (EC 5.4.99.-) in the lanomycin biosynthetic gene cluster; lanomycin is a polyene antifungal compound. The pathway annotation directly matches the expected answer C.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The 337-aa protein contains multiple hydrophobic transmembrane segments and a signal peptide, indicating a membrane-associated enzyme. It is far too small and structurally unlike a polyketide synthase (which are typically >1000 aa multi-domain enzymes), ruling out B. It lacks the characteristic folds and motifs of glycolytic enzymes (ruling out D) or branched-chain amino acid catabolic enzymes (ruling out A). Sequence motifs such as 'GGFDAMDAV' and 'GTELGIFKGHTPS' are reminiscent of terpene cyclase DDxxD and NSE/DTE motifs, suggesting a role in terpenoid/secondary metabolite biosynthesis. Among the four offered pathways, only C ('Antifungal biosynthesis') corresponds to a secondary metabolite biosynthetic pathway involving a small membrane-associated cyclase. Many well-known antifungal natural products (polyenes, terpenoids) are synthesized by pathways involving terpene cyclases, so family-level knowledge of terpene cyclase involvement in antifungal compound biosynthesis supports C over the other options.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The elimination of A (BCAA degradation enzymes are soluble dehydrogenases/transaminases), B (PKS enzymes are very large multi-domain proteins), and D (glycolytic enzymes are well-characterized soluble proteins with distinct motifs) is straightforward from protein size, membrane topology, and absence of relevant catalytic motifs. The positive identification of C is supported by recognizing terpene cyclase-like features and the general biological principle that terpene cyclases participate in secondary metabolite (including antifungal) biosynthetic pathways. Among the four choices, C is the only pathway compatible with a small membrane-associated terpene cyclase.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A, B, and D are clearly incompatible with the sequence features (size, membrane topology, lack of relevant catalytic motifs). Only C remains as a viable pathway for a small membrane-associated secondary metabolite enzyme.


### Important caveats

- The specific 'Antifungal' designation in the pathway name reflects the biological context of lanomycin as an antifungal compound, which is not directly encoded in the sequence. However, among the four offered choices, no other secondary metabolite pathway is available, so elimination plus positive terpene cyclase features suffice.
- The UniProt annotation uses evidence code ECO:0000305 (curator inference from literature), meaning the pathway assignment is based on the published functional characterization of the lanomycin BGC rather than direct experimental demonstration of this single enzyme's role in antifungal activity.
- The organism (Pyrenophora dematioidea, a fungus) is not provided in the input; recognition that this is a fungal secondary metabolite enzyme relies on sequence features alone.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The 337-aa protein contains multiple hydrophobic transmembrane segments and a signal peptide, indicating a membrane-associated enzyme. It is far too small and structurally unlike a polyketide synthase (which are typically >1000 aa multi-domain enzymes), ruling out B. It lacks the characteristic folds and motifs of glycolytic enzymes (ruling out D) or branched-chain amino acid catabolic enzymes (ruling out A). Sequence motifs such as 'GGFDAMDAV' and 'GTELGIFKGHTPS' are reminiscent of terpene cyclase DDxxD and NSE/DTE motifs, suggesting a role in terpenoid/secondary metabolite biosynthesis. Among the four offered pathways, only C ('Antifungal biosynthesis') corresponds to a secondary metabolite biosynthetic pathway involving a small membrane-associated cyclase. Many well-known antifungal natural products (polyenes, terpenoids) are synthesized by pathways involving terpene cyclases, so family-level knowledge of terpene cyclase involvement in antifungal compound biosynthesis supports C over the other options.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The elimination of A (BCAA degradation enzymes are soluble dehydrogenases/transaminases), B (PKS enzymes are very large multi-domain proteins), and D (glycolytic enzymes are well-characterized soluble proteins with distinct motifs) is straightforward from protein size, membrane topology, and absence of relevant catalytic motifs. The positive identification of C is supported by recognizing terpene cyclase-like features and the general biological principle that terpene cyclases participate in secondary metabolite (including antifungal) biosynthetic pathways. Among the four choices, C is the only pathway compatible with a small membrane-associated terpene cyclase."
  },
  "case_id": "pathway_0063",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry P0DXW1 (LAN5_PYRDE) explicitly annotates the pathway as 'Antifungal biosynthesis' (ECO:0000305, curator inference from PubMed:33857369). The protein is a terpene cyclase (EC 5.4.99.-) in the lanomycin biosynthetic gene cluster; lanomycin is a polyene antifungal compound. The pathway annotation directly matches the expected answer C."
  },
  "important_caveats": [
    "The specific 'Antifungal' designation in the pathway name reflects the biological context of lanomycin as an antifungal compound, which is not directly encoded in the sequence. However, among the four offered choices, no other secondary metabolite pathway is available, so elimination plus positive terpene cyclase features suffice.",
    "The UniProt annotation uses evidence code ECO:0000305 (curator inference from literature), meaning the pathway assignment is based on the published functional characterization of the lanomycin BGC rather than direct experimental demonstration of this single enzyme's role in antifungal activity.",
    "The organism (Pyrenophora dematioidea, a fungus) is not provided in the input; recognition that this is a fungal secondary metabolite enzyme relies on sequence features alone."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, B, and D are clearly incompatible with the sequence features (size, membrane topology, lack of relevant catalytic motifs). Only C remains as a viable pathway for a small membrane-associated secondary metabolite enzyme."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0063",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry P0DXW1 (LAN5_PYRDE) explicitly annotates the pathway as 'Antifungal biosynthesis' (ECO:0000305, curator inference from PubMed:33857369). The protein is a terpene cyclase (EC 5.4.99.-) in the lanomycin biosynthetic gene cluster; lanomycin is a polyene antifungal compound. The pathway annotation directly matches the expected answer C.",
    "evidence_ids": ["C5", "H3", "C4"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The 337-aa protein contains multiple hydrophobic transmembrane segments and a signal peptide, indicating a membrane-associated enzyme. It is far too small and structurally unlike a polyketide synthase (which are typically >1000 aa multi-domain enzymes), ruling out B. It lacks the characteristic folds and motifs of glycolytic enzymes (ruling out D) or branched-chain amino acid catabolic enzymes (ruling out A). Sequence motifs such as 'GGFDAMDAV' and 'GTELGIFKGHTPS' are reminiscent of terpene cyclase DDxxD and NSE/DTE motifs, suggesting a role in terpenoid/secondary metabolite biosynthesis. Among the four offered pathways, only C ('Antifungal biosynthesis') corresponds to a secondary metabolite biosynthetic pathway involving a small membrane-associated cyclase. Many well-known antifungal natural products (polyenes, terpenoids) are synthesized by pathways involving terpene cyclases, so family-level knowledge of terpene cyclase involvement in antifungal compound biosynthesis supports C over the other options.",
    "missing_item_specific_fact": "",
    "reason": "The elimination of A (BCAA degradation enzymes are soluble dehydrogenases/transaminases), B (PKS enzymes are very large multi-domain proteins), and D (glycolytic enzymes are well-characterized soluble proteins with distinct motifs) is straightforward from protein size, membrane topology, and absence of relevant catalytic motifs. The positive identification of C is supported by recognizing terpene cyclase-like features and the general biological principle that terpene cyclases participate in secondary metabolite (including antifungal) biosynthetic pathways. Among the four choices, C is the only pathway compatible with a small membrane-associated terpene cyclase."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, B, and D are clearly incompatible with the sequence features (size, membrane topology, lack of relevant catalytic motifs). Only C remains as a viable pathway for a small membrane-associated secondary metabolite enzyme."
  },
  "important_caveats": [
    "The specific 'Antifungal' designation in the pathway name reflects the biological context of lanomycin as an antifungal compound, which is not directly encoded in the sequence. However, among the four offered choices, no other secondary metabolite pathway is available, so elimination plus positive terpene cyclase features suffice.",
    "The UniProt annotation uses evidence code ECO:0000305 (curator inference from literature), meaning the pathway assignment is based on the published functional characterization of the lanomycin BGC rather than direct experimental demonstration of this single enzyme's role in antifungal activity.",
    "The organism (Pyrenophora dematioidea, a fungus) is not provided in the input; recognition that this is a fungal secondary metabolite enzyme relies on sequence features alone."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "P0DXW1",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "03195f3332d36bdd5e7387b1e3471a7b977448073f58c36a12eb518fcb748430",
  "benchmark_sequence_length": 337,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 4,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2025-02-05",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "3f2ff3dca517c7cada001b0d9e2f2388aebcbab4f14d2d2a9a551d33f51517e8",
  "current_source_sequence_sha256": "03195f3332d36bdd5e7387b1e3471a7b977448073f58c36a12eb518fcb748430",
  "current_source_sequence_length": 337,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 2,
  "selected_historical_version": {
    "accession": "P0DXW1",
    "database": "Swiss-Prot",
    "entryVersion": 2,
    "firstRelease": "2025_02/2025_02",
    "firstReleaseDate": "23-Apr-2025",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "LAN5_PYRDE",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "db1acbf2ac66c5648de96f9c489a7a4f13b2cb19c91ff902f8cef92abf8b0704",
  "selected_historical_source_sequence_sha256": "03195f3332d36bdd5e7387b1e3471a7b977448073f58c36a12eb518fcb748430",
  "selected_historical_source_sequence_length": 337,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 2,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXW1.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXW1.json",
  "source_sha256": "3f2ff3dca517c7cada001b0d9e2f2388aebcbab4f14d2d2a9a551d33f51517e8",
  "retrieved_utc": "2026-11-01T06:25:16.733133+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"P0DXW1\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXW1.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXW1.json",
  "source_sha256": "3f2ff3dca517c7cada001b0d9e2f2388aebcbab4f14d2d2a9a551d33f51517e8",
  "retrieved_utc": "2026-11-01T06:25:16.733133+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":4,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2025-02-05\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXW1.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXW1.json",
  "source_sha256": "3f2ff3dca517c7cada001b0d9e2f2388aebcbab4f14d2d2a9a551d33f51517e8",
  "retrieved_utc": "2026-11-01T06:25:16.733133+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"commonName\":\"Helminthosporium dematioideum\",\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Dothideomycetes\",\"Pleosporomycetidae\",\"Pleosporales\",\"Pleosporineae\",\"Pleosporaceae\",\"Pyrenophora\"],\"scientificName\":\"Pyrenophora dematioidea\",\"taxonId\":139229}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXW1.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXW1.json",
  "source_sha256": "3f2ff3dca517c7cada001b0d9e2f2388aebcbab4f14d2d2a9a551d33f51517e8",
  "retrieved_utc": "2026-11-01T06:25:16.733133+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"Lanomycin biosynthesis cluster protein 5\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"5.4.99.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"Terpene cyclase\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXW1.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXW1.json",
  "source_sha256": "3f2ff3dca517c7cada001b0d9e2f2388aebcbab4f14d2d2a9a551d33f51517e8",
  "retrieved_utc": "2026-11-01T06:25:16.733133+00:00",
  "json_pointer": "/comments/1",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"Antifungal biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXW1.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXW1.json",
  "source_sha256": "3f2ff3dca517c7cada001b0d9e2f2388aebcbab4f14d2d2a9a551d33f51517e8",
  "retrieved_utc": "2026-11-01T06:25:16.733133+00:00",
  "json_pointer": "/references/0",
  "excerpt": "{\"citation\":{\"authors\":[\"Liu N.\",\"Abramyan E.D.\",\"Cheng W.\",\"Perlatti B.\",\"Harvey C.J.B.\",\"Bills G.F.\",\"Tang Y.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"33857369\"},{\"database\":\"DOI\",\"id\":\"10.1021/jacs.1c01516\"}],\"citationType\":\"journal article\",\"firstPage\":\"6043\",\"id\":\"33857369\",\"journal\":\"J. Am. Chem. Soc.\",\"lastPage\":\"6047\",\"publicationDate\":\"2021\",\"title\":\"Targeted genome mining reveals the biosynthetic gene clusters of natural product CYP51 inhibitors.\",\"volume\":\"143\"},\"referenceComments\":[{\"type\":\"STRAIN\",\"value\":\"TTI-1096\"}],\"referenceNumber\":1,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [GENOMIC DNA]\",\"FUNCTION\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXW1?format=txt&versions=2)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXW1?format=txt&versions=2",
  "source_sha256": "db1acbf2ac66c5648de96f9c489a7a4f13b2cb19c91ff902f8cef92abf8b0704",
  "retrieved_utc": "2026-11-01T06:28:24.266216+00:00",
  "source_locator": "lines 1-14",
  "excerpt": "ID   LAN5_PYRDE              Reviewed;         337 AA.\nAC   P0DXW1;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   05-FEB-2025, sequence version 1.\nDT   09-APR-2025, entry version 2.\nDE   RecName: Full=Terpene cyclase {ECO:0000303|PubMed:33857369};\nDE            EC=5.4.99.- {ECO:0000305|PubMed:33857369};\nDE   AltName: Full=Lanomycin biosynthesis cluster protein 5 {ECO:0000303|PubMed:33857369};\nGN   Name=ORF5 {ECO:0000303|PubMed:33857369};\nOS   Pyrenophora dematioidea (Helminthosporium dematioideum).\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Dothideomycetes;\nOC   Pleosporomycetidae; Pleosporales; Pleosporineae; Pleosporaceae;\nOC   Pyrenophora.\nOX   NCBI_TaxID=139229;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 2,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXW1?format=txt&versions=2)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXW1?format=txt&versions=2",
  "source_sha256": "db1acbf2ac66c5648de96f9c489a7a4f13b2cb19c91ff902f8cef92abf8b0704",
  "retrieved_utc": "2026-11-01T06:28:24.266216+00:00",
  "source_locator": "lines 15-23",
  "excerpt": "RN   [1]\nRP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND PATHWAY.\nRC   STRAIN=TTI-1096;\nRX   PubMed=33857369; DOI=10.1021/jacs.1c01516;\nRA   Liu N., Abramyan E.D., Cheng W., Perlatti B., Harvey C.J.B., Bills G.F.,\nRA   Tang Y.;\nRT   \"Targeted genome mining reveals the biosynthetic gene clusters of natural\nRT   product CYP51 inhibitors.\";\nRL   J. Am. Chem. Soc. 143:6043-6047(2021).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 2,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXW1?format=txt&versions=2)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXW1?format=txt&versions=2",
  "source_sha256": "db1acbf2ac66c5648de96f9c489a7a4f13b2cb19c91ff902f8cef92abf8b0704",
  "retrieved_utc": "2026-11-01T06:28:24.266216+00:00",
  "source_locator": "lines 34-34",
  "excerpt": "CC   -!- PATHWAY: Antifungal biosynthesis. {ECO:0000305|PubMed:33857369}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 2,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 63. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
